IPV ¹é½Å ½ÃÀå : ¹é½Å ºê·£µåº°, À¯Åë ä³Îº°, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2025-2032³â)
IPV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
»óǰÄÚµå : 1708584
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,258,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,735,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,908,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

IPV ¹é½Å ¼¼°è ½ÃÀåÀº 2025³â 1¾ï 9,990¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 3¾ï 5,850¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â µ¿¾È 8.7%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 1¾ï 9,990¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 8.70% 2032³â ±Ý¾× ¿¹Ãø 3¾ï 5,850¸¸ ´Þ·¯
±×¸². IPV ¹é½Å ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
IPV Vaccines Market-IMG1

ºÒȰ¼ºÈ­ ¼Ò¾Æ¸¶ºñ ¹é½Å(IPV)Àº ¼ÒÅ©¹é½ÅÀ̶ó°íµµ ÇÕ´Ï´Ù. ¼Ò¾Æ¸¶ºñ ¹é½Å¿¡´Â ºÒȰ¼ºÈ­ ¼Ò¾Æ¸¶ºñ ¹é½Å°ú °æ±¸¿ë ¼Ò¾Æ¸¶ºñ ¹é½ÅÀÇ µÎ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, IPV ¹é½ÅÀº ÁÖ·Î ÆÈ°ú ´Ù¸®¿¡ ÁÖ»çÇÕ´Ï´Ù.

°è¶õÀ̳ª ½ºÆ®·¾Å丶À̽Űú °°Àº ¾à¹°¿¡ ¾Ë·¹¸£±â°¡ ÀÖ´Â »ç¶÷Àº IPV Áֻ縦 ¸ÂÀ¸¸é ¾ÈµÇ¸ç, IPV´Â ¹é½Å Á¢Á¾ ´ë»óÀÚ°¡ Àå±â°£ ½ºÅ×·ÎÀ̵å Ä¡·á¸¦ ¹Þ°í Àְųª, ¾ÏÀ» ¾Î°í Àְųª, È­Çпä¹ýÀ» ¹Þ°í Àְųª, Áý¿¡ ¸é¿ª·ÂÀÌ ¾ø´Â ¼ºÀÎÀÌ ÀÖ´Â °æ¿ì¿¡¸¸ Á¢Á¾ÇØ¾ß ÇÕ´Ï´Ù. °æ¿ì¿¡¸¸ Á¢Á¾ÇÕ´Ï´Ù.

IPV ¹é½Å ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 1¾ï 9,990¸¸ ´Þ·¯·Î 2032³â¿¡´Â 3¾ï 5,850¸¸ ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 8.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼Ò¾Æ¸¶ºñ ¹ß»ýÀ» ¿¹¹æÇϱâ À§ÇØ ¿©·¯ Á¤ºÎ°¡ ¿¹¹æ Á¢Á¾¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇØ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖ½À´Ï´Ù. °ø°ø ±â°üÀº °¡³­ÇÑ »ç¶÷µé¿¡°Ô ¿¹¹æÁ¢Á¾À» Á¦°øÇϱâ À§ÇØ À¯ÀÍÇÑ ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥À» µµÀÔÇϰí ÀÖÀ¸¸ç, ÀÌ´Â °¡±î¿î Àå·¡¿¡ ¼¼°è ºÒȰ¼ºÈ­ ¼Ò¾Æ¸¶ºñ ¹é½Å ½ÃÀå(IPV)ÀÇ ¼ºÀå¿¡ ¸Å¿ì À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 9¿ù °¡³ª º¸°ÇºÎ(GHS)´Â °íÀ§Çè Áö¿ª¿¡¼­ÀÇ ¹ÙÀÌ·¯½º È®»êÀ» ¹æÁöÇϱâ À§ÇØ ÀÏ·ÃÀÇ ¼Ò¾Æ¸¶ºñ ¹é½Å Á¢Á¾/¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ¼Ò¾Æ¸¶ºñ ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀº ºÒȰ¼ºÈ­ ¼Ò¾Æ¸¶ºñ ¹é½Å(IPV)À» »ç¿ëÇÏ¿© °¡³ª Àü¿ªÀÇ ¸ðµç Áö¿ª¿¡¼­ 2016³â 1¿ùºÎÅÍ 2018³â 6¿ù±îÁö Ãâ»ýÇÑ ¸ðµç ¾î¸°ÀÌ¿¡°Ô ¿¹¹æÁ¢Á¾À» ½Ç½ÃÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå Áß¿äÇÑ ÀλçÀÌÆ®

Á¦4Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹é½Å ºê·£µåº°, 2020-2032³â

Á¦5Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹é½Å À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, ¹ÙÀÌ¾Ë À¯Çüº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä - ¼¼°èÀÇ IPV ¹é½Å ½ÃÀå

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ipv Vaccines Market is estimated to be valued at USD 199.9 Mn in 2025 and is expected to reach USD 358.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 199.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: USD 358.5 Mn
Figure. Ipv Vaccines Market Share (%), By Region 2025
IPV Vaccines Market - IMG1

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Key Insights

4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)

8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)

9. Competitive Landscape

10. Company Profiles - Global IPV Vaccines Market

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â